Skip to main content
Premium Trial:

Request an Annual Quote

Biosearch Gets $3.4M Contract from FDA

NEW YORK (GenomeWeb News) – Biosearch Technologies today announced that the US Food and Drug Administration has awarded the firm a $3.4 million contract to develop rapid, multiplexed fluorescent assays for identifying bioterror and food safety pathogens.

The Novato, Calif.-based firm said that it will work with Pejman Naraghi-Arani at Lawrence Livermore National Laboratories and Luminex to develop rapid, highly specific assays for agents listed as "Select Agents" by the Centers for Disease Control and Prevention and the US Department of Agriculture. The assays will run on the Luminex xMAP platform.

Initial target analytes for the project include Bacillus anthracis, Yersinia pestis, and Francisells tularensis.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.